The EVD Drain Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (External Ventricular Drainage Set, Accessories), By Application (Traumatic Brain Injury, Intracranial Hemorrhage, Hydrocephalus, Others), By End-User (Hospitals, Ambulatory Surgery Centers (ASCs)).
In 2024, the market for external ventricular drainage (EVD) systems addresses the critical role of neurosurgical interventions in managing intracranial pressure (ICP) and cerebrospinal fluid (CSF) dynamics in patients with acute neurological conditions such as traumatic brain injury, subarachnoid hemorrhage, and hydrocephalus. EVD drains are specialized medical devices used to remove excess CSF from the brain ventricles, monitor intracranial pressure, and prevent neurological complications associated with elevated ICP, including brain herniation and cerebral edema. These systems typically consist of an intraventricular catheter inserted into the cerebral ventricles, connected to an external drainage system comprising a collection bag, pressure monitoring transducer, and adjustable valve for regulating CSF drainage rate. EVD drains allow for continuous monitoring of ICP trends, adjustment of CSF drainage rates based on clinical status, and therapeutic interventions such as CSF drainage, CSF sampling, or intracranial pressure management in neurocritical care settings. With a focus on patient safety, accuracy, and infection control, EVD drains undergo strict sterile technique, aseptic insertion procedures, and monitoring protocols to minimize the risk of catheter-related infections, hemorrhagic complications, or malpositioning of the drainage system. Moreover, with advancements in catheter design, valve technology, and drainage management algorithms, the EVD drain market continues to innovate, offering improved performance, user-friendly features, and integrated monitoring capabilities for optimizing patient outcomes, reducing complications, and enhancing neurocritical care in patients with acute brain injuries or neurosurgical conditions.
A prominent trend in the EVD (External Ventricular Drain) market is the increasing adoption of minimally invasive neurosurgical techniques. EVDs are critical devices used in neurosurgical procedures to drain cerebrospinal fluid (CSF) from the brain's ventricles, often in cases of hydrocephalus, traumatic brain injury, or intracranial hemorrhage. Recent advancements in neurosurgical technologies and techniques have facilitated the transition towards minimally invasive approaches for EVD placement. These techniques involve smaller incisions, precise catheter placement, and reduced tissue trauma, leading to shorter hospital stays, faster recovery times, and improved patient outcomes. The adoption of minimally invasive EVD procedures reflects the industry's commitment to enhancing patient safety, surgical precision, and postoperative recovery, driving market growth and innovation in the EVD drain segment.
A key driver for the EVD drain market is the rising incidence of neurological disorders and traumatic brain injuries (TBIs) worldwide. Neurological conditions such as hydrocephalus, intracranial hemorrhage, and brain tumors require prompt and effective management of intracranial pressure (ICP) through CSF drainage. Additionally, TBIs resulting from accidents falls, or sports injuries often lead to increased ICP and require urgent intervention to prevent secondary brain injury. EVDs play a crucial role in monitoring and managing ICP levels, reducing the risk of cerebral edema, herniation, and neurological complications in these patient populations. The growing prevalence of neurological disorders, coupled with improvements in trauma care and neurocritical care protocols, drives demand for EVD drains as essential tools in the management of intracranial pressure and cerebral perfusion, supporting market growth and adoption of EVD devices.
An opportunity for innovation and market expansion in the EVD drain market lies in the development of integrated monitoring and management systems. EVD placement and management involve continuous monitoring of ICP, CSF drainage rates, and neurological status to optimize patient outcomes and prevent complications. By integrating EVD drains with advanced monitoring technologies such as intracranial pressure monitors, microdialysis systems, and cerebral oximetry devices, clinicians can gather real-time data, detect changes in cerebral physiology, and adjust treatment strategies accordingly. Additionally, there is an opportunity to develop software platforms and decision support tools that streamline EVD management, automate data analysis, and provide actionable insights to healthcare providers. This integration enhances patient care, facilitates clinical decision-making, and improves outcomes for patients undergoing EVD procedures. By capitalizing on the synergies between EVD drains and monitoring technologies, companies can address unmet clinical needs, enhance product value, and capture new opportunities in the evolving neurocritical care market.
The External Ventricular Drainage (EVD) Set segment within the EVD Drain market is experiencing rapid growth due to several factors driving the demand for effective cerebrospinal fluid (CSF) management in patients with neurological conditions such as traumatic brain injury, intracranial hemorrhage, and hydrocephalus. EVD sets are specialized medical devices used to drain excess CSF from the brain's ventricles, thereby reducing intracranial pressure and preventing complications such as brain herniation and cerebral edema. These sets typically consist of catheters, drainage bags, and monitoring systems that allow healthcare providers to safely and accurately regulate CSF drainage based on patient-specific needs. With the increasing incidence of traumatic brain injuries, strokes, and other neurosurgical emergencies, there is a growing demand for EVD sets as essential tools in the management of intracranial pressure and cerebral perfusion. EVD sets offer advantages such as real-time monitoring of intracranial pressure, precise control over CSF drainage rates, and the ability to assess CSF biochemistry and cytology for diagnostic purposes. Additionally, advancements in EVD set design, including the development of antimicrobial catheters, closed drainage systems, and integrated pressure monitoring devices, enhance the safety and efficacy of CSF drainage procedures. Hospitals and ambulatory surgery centers (ASCs) are increasingly adopting EVD sets as standard-of-care devices for neurocritical care patients, driven by the growing recognition of the importance of early and aggressive management of intracranial hypertension. As healthcare facilities continue to invest in advanced neurosurgical technologies and protocols to improve patient outcomes in neurological emergencies, the External Ventricular Drainage Set segment is poised for significant growth in the EVD Drain market, offering essential solutions for CSF management in critically ill patients with intracranial pathologies.
The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossB. Braun Melsungen AG, Cadila Healthcare Ltd, Dispomedica GmbH, FUJIFILM Systems Corp, Geistlich Pharma Inc, Integra LifeSciences Corp, Johnson & Johnson, Medtronic plc, Möller Medical GmbH, Pfizer Inc, Sophysa SA, Spiegelberg GmbH & Co. KG
By Product
External Ventricular Drainage Set
Accessories
By Application
Traumatic Brain Injury
Intracranial Hemorrhage
Hydrocephalus
Others
By End-User
Hospitals
Ambulatory Surgery Centers (ASCs)
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
B. Braun Melsungen AG
Cadila Healthcare Ltd
Dispomedica GmbH
FUJIFILM Systems Corp
Geistlich Pharma Inc
Integra LifeSciences Corp
Johnson & Johnson
Medtronic plc
Möller Medical GmbH
Pfizer Inc
Sophysa SA
Spiegelberg GmbH & Co. KG
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the EVD Drain Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the EVD Drain Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 EVD Drain Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global EVD Drain Market Size Outlook, $ Million, 2021 to 2030
3.2 EVD Drain Market Outlook by Type, $ Million, 2021 to 2030
3.3 EVD Drain Market Outlook by Product, $ Million, 2021 to 2030
3.4 EVD Drain Market Outlook by Application, $ Million, 2021 to 2030
3.5 EVD Drain Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of EVD Drain Industry
4.2 Key Market Trends in EVD Drain Industry
4.3 Potential Opportunities in EVD Drain Industry
4.4 Key Challenges in EVD Drain Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global EVD Drain Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global EVD Drain Market Outlook by Segments
7.1 EVD Drain Market Outlook by Segments, $ Million, 2021- 2030
By Product
External Ventricular Drainage Set
Accessories
By Application
Traumatic Brain Injury
Intracranial Hemorrhage
Hydrocephalus
Others
By End-User
Hospitals
Ambulatory Surgery Centers (ASCs)
8 North America EVD Drain Market Analysis and Outlook To 2030
8.1 Introduction to North America EVD Drain Markets in 2024
8.2 North America EVD Drain Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America EVD Drain Market size Outlook by Segments, 2021-2030
By Product
External Ventricular Drainage Set
Accessories
By Application
Traumatic Brain Injury
Intracranial Hemorrhage
Hydrocephalus
Others
By End-User
Hospitals
Ambulatory Surgery Centers (ASCs)
9 Europe EVD Drain Market Analysis and Outlook To 2030
9.1 Introduction to Europe EVD Drain Markets in 2024
9.2 Europe EVD Drain Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe EVD Drain Market Size Outlook by Segments, 2021-2030
By Product
External Ventricular Drainage Set
Accessories
By Application
Traumatic Brain Injury
Intracranial Hemorrhage
Hydrocephalus
Others
By End-User
Hospitals
Ambulatory Surgery Centers (ASCs)
10 Asia Pacific EVD Drain Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific EVD Drain Markets in 2024
10.2 Asia Pacific EVD Drain Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific EVD Drain Market size Outlook by Segments, 2021-2030
By Product
External Ventricular Drainage Set
Accessories
By Application
Traumatic Brain Injury
Intracranial Hemorrhage
Hydrocephalus
Others
By End-User
Hospitals
Ambulatory Surgery Centers (ASCs)
11 South America EVD Drain Market Analysis and Outlook To 2030
11.1 Introduction to South America EVD Drain Markets in 2024
11.2 South America EVD Drain Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America EVD Drain Market size Outlook by Segments, 2021-2030
By Product
External Ventricular Drainage Set
Accessories
By Application
Traumatic Brain Injury
Intracranial Hemorrhage
Hydrocephalus
Others
By End-User
Hospitals
Ambulatory Surgery Centers (ASCs)
12 Middle East and Africa EVD Drain Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa EVD Drain Markets in 2024
12.2 Middle East and Africa EVD Drain Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa EVD Drain Market size Outlook by Segments, 2021-2030
By Product
External Ventricular Drainage Set
Accessories
By Application
Traumatic Brain Injury
Intracranial Hemorrhage
Hydrocephalus
Others
By End-User
Hospitals
Ambulatory Surgery Centers (ASCs)
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
B. Braun Melsungen AG
Cadila Healthcare Ltd
Dispomedica GmbH
FUJIFILM Systems Corp
Geistlich Pharma Inc
Integra LifeSciences Corp
Johnson & Johnson
Medtronic plc
Möller Medical GmbH
Pfizer Inc
Sophysa SA
Spiegelberg GmbH & Co. KG
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
External Ventricular Drainage Set
Accessories
By Application
Traumatic Brain Injury
Intracranial Hemorrhage
Hydrocephalus
Others
By End-User
Hospitals
Ambulatory Surgery Centers (ASCs)
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
The global EVD Drain Market is one of the lucrative growth markets, poised to register a 7.2% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
B. Braun Melsungen AG, Cadila Healthcare Ltd, Dispomedica GmbH, FUJIFILM Systems Corp, Geistlich Pharma Inc, Integra LifeSciences Corp, Johnson & Johnson, Medtronic plc, Möller Medical GmbH, Pfizer Inc, Sophysa SA, Spiegelberg GmbH & Co. KG
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume